Kinetics of Neutralizing Antibodies of COVID-19 Patients Tested Using Clinical D614G, B.1.1.7, and B 1.351 Isolates in Microneutralization Assays

Kinetics of Neutralizing Antibodies of COVID-19 Patients Tested Using Clinical D614G, B.1.1.7, and B 1.351 Isolates in Microneutralization Assays

Increasing evidence suggests that some newly emerged SARS-CoV-2 variants of concern (VoCs) resist neutralization by antibodies elicited by the early-pandemic wild-type virus. We applied neutralization tests to paired recoveree sera (<i>n</i> = 38) using clinical isolates representing the...

Full description

Bibliographic Details
Main Authors: Jenni Virtanen, Ruut Uusitalo, Essi M. Korhonen, Kirsi Aaltonen, Teemu Smura, Suvi Kuivanen, Sari H. Pakkanen, Sointu Mero, Anu Patjas, Marianna Riekkinen, Anu Kantele, Visa Nurmi, Klaus Hedman, Jussi Hepojoki, Tarja Sironen, Eili Huhtamo, Olli Vapalahti
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Viruses
Subjects:
SARS-CoV-2
neutralizing antibodies
immunity
Online Access:https://www.mdpi.com/1999-4915/13/6/996

Similar Items

Similar Items